NZ333813A - Pharmaceutical composition containing a 5HT2C antagonist and a D2 antagonist - Google Patents

Pharmaceutical composition containing a 5HT2C antagonist and a D2 antagonist

Info

Publication number: NZ333813A
Authority: NZ; New Zealand
Prior art keywords: antagonist; pharmaceutical composition; 5ht2c; composition containing; compound
Prior art date: 1996-07-26

Application number

NZ333813A

Other languages

English (en)

Inventor

Thomas Paul Blackburn

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-07-26

Filing date

1997-07-22

Publication date

2000-07-28

1997-07-22 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

2000-07-28 Publication of NZ333813A publication Critical patent/NZ333813A/xx

Links

239000005557 antagonist Substances 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title abstract 2
239000002484 serotonin 2C antagonist Substances 0.000 title abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
ZETBBVYSBABLHL-UHFFFAOYSA-N SB 243213 Chemical compound C1=2C=C(C(F)(F)F)C(C)=CC=2CCN1C(=O)NC(C=N1)=CC=C1OC1=CC=CN=C1C ZETBBVYSBABLHL-UHFFFAOYSA-N 0.000 abstract 1
208000015114 central nervous system disease Diseases 0.000 abstract 1
229960005017 olanzapine Drugs 0.000 abstract 1
KVWDHTXUZHCGIO-UHFFFAOYSA-N olanzapine Chemical compound C1CN(C)CCN1C1=NC2=CC=CC=C2NC2=C1C=C(C)S2 KVWDHTXUZHCGIO-UHFFFAOYSA-N 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
229960004431 quetiapine Drugs 0.000 abstract 1
URKOMYMAXPYINW-UHFFFAOYSA-N quetiapine Chemical compound C1CN(CCOCCO)CCN1C1=NC2=CC=CC=C2SC2=CC=CC=C12 URKOMYMAXPYINW-UHFFFAOYSA-N 0.000 abstract 1
201000000980 schizophrenia Diseases 0.000 abstract 1
229960000652 sertindole Drugs 0.000 abstract 1
GZKLJWGUPQBVJQ-UHFFFAOYSA-N sertindole Chemical compound C1=CC(F)=CC=C1N1C2=CC=C(Cl)C=C2C(C2CCN(CCN3C(NCC3)=O)CC2)=C1 GZKLJWGUPQBVJQ-UHFFFAOYSA-N 0.000 abstract 1
229960000607 ziprasidone Drugs 0.000 abstract 1
MVWVFYHBGMAFLY-UHFFFAOYSA-N ziprasidone Chemical compound C1=CC=C2C(N3CCN(CC3)CCC3=CC=4CC(=O)NC=4C=C3Cl)=NSC2=C1 MVWVFYHBGMAFLY-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Neurosurgery (AREA)
General Chemical & Material Sciences (AREA)
Psychiatry (AREA)
Neurology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NZ333813A 1996-07-26 1997-07-22 Pharmaceutical composition containing a 5HT2C antagonist and a D2 antagonist NZ333813A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9615767.2A GB9615767D0 (en)	1996-07-26	1996-07-26	Novel treatment
PCT/EP1997/004159 WO1998004289A2 (en)	1996-07-26	1997-07-22	Pharmaceutical composition containing a 5ht2c antagonist and a d2 antagonist

Publications (1)

Publication Number	Publication Date
NZ333813A true NZ333813A (en)	2000-07-28

Family

ID=10797573

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NZ333813A NZ333813A (en)	1996-07-26	1997-07-22	Pharmaceutical composition containing a 5HT2C antagonist and a D2 antagonist

Country Status (19)

Country	Link
EP (1)	EP0936924A2 (cs)
JP (1)	JP2000516924A (cs)
KR (1)	KR20000029564A (cs)
CN (1)	CN1230894A (cs)
AR (1)	AR008083A1 (cs)
AU (1)	AU725817B2 (cs)
BR (1)	BR9710568A (cs)
CA (1)	CA2261813A1 (cs)
CO (1)	CO5031292A1 (cs)
CZ (1)	CZ23799A3 (cs)
GB (1)	GB9615767D0 (cs)
HU (1)	HUP9903619A3 (cs)
IL (1)	IL128219A0 (cs)
NO (1)	NO990322L (cs)
NZ (1)	NZ333813A (cs)
PL (1)	PL331426A1 (cs)
TR (1)	TR199900140T2 (cs)
WO (1)	WO1998004289A2 (cs)
ZA (1)	ZA976593B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9612883D0 (en) *	1996-06-20	1996-08-21	Smithkline Beecham Plc	Novel compounds
EP1133299A1 (en)	1998-11-23	2001-09-19	Sepracor Inc.	2-hydroxymethylolanzapine compositions and methods
CA2351718A1 (en)	1998-11-23	2000-06-02	Sepracor Inc.	Desmethylolanzapine compositions and methods
JP2002530340A (ja) *	1998-11-23	2002-09-17	セプラコール，インク．	オランザピン−ｎ−オキサイドを含む医薬組成物
AU3757500A (en) *	1999-03-18	2000-10-04	Childrens Hospital Research Foundation	A method of treating bulimia nervosa and related eating disorders by administration of atypical antipsychotic medications
CA2363784A1 (en) *	1999-05-19	2000-11-30	Astrazeneca Ab	Method of treatment
WO2005013969A1 (en) *	2003-07-15	2005-02-17	Janssen Pharmaceutica N.V.	Antipsychotic agent with socializing properties

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9500998D0 (sv) *	1995-03-19	1995-03-19	Haakan Wilhelm Wikstroem	New sulfone ester analogues of iso-clozapine and related structures: atypical neuroleptics

1996
- 1996-07-26 GB GBGB9615767.2A patent/GB9615767D0/en active Pending
1997
- 1997-07-22 CA CA002261813A patent/CA2261813A1/en not_active Abandoned
- 1997-07-22 WO PCT/EP1997/004159 patent/WO1998004289A2/en not_active Ceased
- 1997-07-22 HU HU9903619A patent/HUP9903619A3/hu unknown
- 1997-07-22 IL IL12821997A patent/IL128219A0/xx unknown
- 1997-07-22 NZ NZ333813A patent/NZ333813A/xx unknown
- 1997-07-22 AU AU42972/97A patent/AU725817B2/en not_active Ceased
- 1997-07-22 TR TR1999/00140T patent/TR199900140T2/xx unknown
- 1997-07-22 JP JP10508522A patent/JP2000516924A/ja active Pending
- 1997-07-22 CZ CZ99237A patent/CZ23799A3/cs unknown
- 1997-07-22 CN CN97197977A patent/CN1230894A/zh active Pending
- 1997-07-22 PL PL97331426A patent/PL331426A1/xx unknown
- 1997-07-22 KR KR1019997000622A patent/KR20000029564A/ko not_active Withdrawn
- 1997-07-22 BR BR9710568A patent/BR9710568A/pt not_active Application Discontinuation
- 1997-07-22 EP EP97918947A patent/EP0936924A2/en not_active Ceased
- 1997-07-24 ZA ZA976593A patent/ZA976593B/xx unknown
- 1997-07-24 AR ARP970103348A patent/AR008083A1/es not_active Application Discontinuation
- 1997-07-25 CO CO97042582A patent/CO5031292A1/es unknown
1999
- 1999-01-25 NO NO990322A patent/NO990322L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
BR9710568A (pt)	1999-08-17
IL128219A0 (en)	1999-11-30
KR20000029564A (ko)	2000-05-25
NO990322D0 (no)	1999-01-25
CN1230894A (zh)	1999-10-06
TR199900140T2 (xx)	1999-03-22
CO5031292A1 (es)	2001-04-27
NO990322L (no)	1999-03-24
CZ23799A3 (cs)	1999-06-16
HUP9903619A2 (hu)	2000-10-28
EP0936924A2 (en)	1999-08-25
ZA976593B (en)	1999-01-25
WO1998004289A3 (en)	1998-03-19
GB9615767D0 (en)	1996-09-04
JP2000516924A (ja)	2000-12-19
WO1998004289A2 (en)	1998-02-05
AR008083A1 (es)	1999-12-09
CA2261813A1 (en)	1998-02-05
HUP9903619A3 (en)	2001-03-28
PL331426A1 (en)	1999-07-19
AU4297297A (en)	1998-02-20
AU725817B2 (en)	2000-10-19

Similar Documents

Publication	Publication Date	Title
HU9602932D0 (en)	1996-12-30	Substituted imidazolidine-2,4-dion compounds as pharmaceutical agent
HUP9601419A2 (en)	1997-09-29	Synergetic pharmaceutical compositions for treating parkinson-disease
HUP0004693A3 (en)	2001-12-28	Oxo-substituted compounds inhibiting parp activity, pharmaceutical compositions containing them and process for preparation the compounds
ZA988012B (en)	1999-03-03	Amino-substituted compounds methods and compositions for inhibiting parp activity
HU9600765D0 (en)	1996-05-28	Use of a cgrp antagonist for treating skin redness of neurogenic origin, and compositions containing these compounds
IL127244A0 (en)	1999-09-22	Pharmaceutical for treatment of neurological and neuropsychiatric disorders
BG102872A (en)	1999-11-30	6-phenylpyridyl-3-amine derivatives
HUP0103344A3 (en)	2002-03-28	Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp), process for their preparation and pharmaceutical compositions containing them
ZA9810607B (en)	1999-11-11	Flushable individual packages for absorbent articles.
PL330752A1 (en)	1999-05-24	Pharmaceutical agent for treating urinary incontinence
EP0825867A4 (en)	2000-05-31	N, O-CARBOXYMETHYLCHITOSAN FOR THE PREVENTION OF SURGICAL ADHESIONS
IL117079A (en)	1999-12-31	Pharmaceutical compositions containing 2-phenyl-2-aroyl-benzothiophenes for inhibiting cell-cell adhesion
ZA9610543B (en)	1998-01-08	Compounds and compositions for reducing blood glucose and/or inhibiting the activity of CGRP.
HUP9602943A3 (en)	1998-03-02	Composition for inhibiting angiogenesis
ZA9811629B (en)	2000-06-19	The use of MMP inhibitors for the treatment of ocular angiogenesis.
HUT73854A (en)	1996-09-30	Antipsychotic pharmaceutical compositions containing azabicyclo-thiadiazolo- or azabicyclo-oxadiazolo-derivatives
NZ333813A (en)	2000-07-28	Pharmaceutical composition containing a 5HT2C antagonist and a D2 antagonist
HU9801924D0 (en)	1998-10-28	Pharmaceutica composition for treating heart- and vascular troubles containing sodium-hydrogen-change-inhibitors
PL312908A1 (en)	1996-09-02	Drugs for treating aids and/or hiv infections, containing composition consisting of quinoxalin and protease inhibitors
HUP0100611A3 (en)	2003-03-28	Triazine compounds for treatment of cns disorders
HUP9800396A3 (en)	2001-05-28	Pharmaceutical composition for treating dementia
GB9611614D0 (en)	1996-08-07	Process for inhibiting the effect of flourescent whitening agents
HU9600764D0 (en)	1996-05-28	Use of a cgrp antagonist for treating lichens and pruritus, and compositions containing this compound
IL117970A (en)	1999-12-22	Pharmaceutical compositions containing olanzapine for treating nicotine withdrawal
EP1009403A4 (en)	2002-08-28	METHOD FOR TREATING SCHIZOPHRENIA

Legal Events

Date	Code	Title	Description
2001-07-27	RENW	Renewal (renewal fees accepted)